Osamu Sawada
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Osamu Sawada has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Masashi Kakinoki
Department of Ophthalmology, Shiga University of Medical Science, Otsu, Japan
10 shared publicationsMasahito Ohji
9 shared publicationsHajime Kawamura
Department of Ophthalmology, Shiga University of Medical Science, Otsu, Japan
7 shared publicationsTomoko Sawada
Department of Ophthalmology, Shiga University of Medical Science, Otsu, Japan
6 shared publications- Masahito Ohji
Department of Ophthalmology, Shiga University of Medical Science, Otsu, Japan
3 shared publications Taichiro Miyake
Department of Ophthalmology, Shiga University of Medical Science, Otsu, Japan
3 shared publications
Latest Publications
- 1 October 2026
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
Dilated pupil vertical-to-horizontal ratio as a predictor of intraoperative floppy-iris syndrome
Purpose: To investigate whether intraoperative floppy-iris syndrome (IFIS) can be predicted from pupil morphology, including vertical pupil elongation and pupillary diameter. Setting: Shiga University of Medical Science Hospital, Shiga, Japan. Design: Retrospective observational study. Methods: Patients who underwent standalone phacoemulsification cataract surgery between November 2022 and April 2023 were retrospectively reviewed. In bilateral cases, only the first-operated eye was included. Eyes with prior ocular surgery or conditions affecting pupil morphology were excluded. Surgical videos were reviewed to assess pupil morphology parameters, including the pupil vertical-to-horizontal ratio (PVHR) and the composite pupil-to-corneal diameter ratio (CPCDR) at the beginning of surgery, and to evaluate IFIS incidence. IFIS incidence was treated as the outcome variable. Explanatory variables comprised age, sex, hypertension, diabetes mellitus, α1-adrenergic antagonist use, and pupil morphology parameters. Associations were evaluated using logistic regression. Results: 263 patients (263 eyes) were included of whom 23 eyes (8.7%) developed IFIS. PVHR was significantly higher in eyes with vs without IFIS (median: 1.06 vs 1.03; P < .001), while CPCDR was significantly lower (0.56 vs 0.70; P < .001). In the multivariate logistic regression analysis, PVHR (odds ratio: 4.06; P = .0005) and CPCDR (odds ratio: 0.43; P < .0001) were independently associated with IFIS. Conclusions: Vertical pupil elongation and poor dilation after pharmacologic mydriasis were independently associated with IFIS. Assessment of pupil shape, in addition to pupil size, may improve preoperative identification of eyes at risk for IFIS.
- 1 October 2026
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
Dilated pupil vertical-to-horizontal ratio as a predictor of intraoperative floppy-iris syndrome
Purpose: To investigate whether intraoperative floppy-iris syndrome (IFIS) can be predicted from pupil morphology, including vertical pupil elongation and pupillary diameter. Setting: Shiga University of Medical Science Hospital, Shiga, Japan. Design: Retrospective observational study. Methods: Patients who underwent standalone phacoemulsification cataract surgery between November 2022 and April 2023 were retrospectively reviewed. In bilateral cases, only the first-operated eye was included. Eyes with prior ocular surgery or conditions affecting pupil morphology were excluded. Surgical videos were reviewed to assess pupil morphology parameters, including the pupil vertical-to-horizontal ratio (PVHR) and the composite pupil-to-corneal diameter ratio (CPCDR) at the beginning of surgery, and to evaluate IFIS incidence. IFIS incidence was treated as the outcome variable. Explanatory variables comprised age, sex, hypertension, diabetes mellitus, α1-adrenergic antagonist use, and pupil morphology parameters. Associations were evaluated using logistic regression. Results: 263 patients (263 eyes) were included of whom 23 eyes (8.7%) developed IFIS. PVHR was significantly higher in eyes with vs without IFIS (median: 1.06 vs 1.03; P < .001), while CPCDR was significantly lower (0.56 vs 0.70; P < .001). In the multivariate logistic regression analysis, PVHR (odds ratio: 4.06; P = .0005) and CPCDR (odds ratio: 0.43; P < .0001) were independently associated with IFIS. Conclusions: Vertical pupil elongation and poor dilation after pharmacologic mydriasis were independently associated with IFIS. Assessment of pupil shape, in addition to pupil size, may improve preoperative identification of eyes at risk for IFIS.
- 17 April 2022
- Published by Springer Nature in Japanese Journal of Ophthalmology
- Vol. 66 (3) , 335-340
Efficacy of scleral imbrication on all quadrants in enucleated pig eyes
Purpose To evaluate the changes in axial length (AL) and corneal astigmatism induced by scleral imbrication on all quadrants in pig eyes. Study design Experimental study Methods We produced scleral imbrications either on all quadrants or on 2 consecutive quadrants of 5 enucleated pig eyes. Scleral imbrications 8 mm wide were made at 8 mm from the limbus on each quadrant. We determined the AL using an electronic caliper and the corneal astigmatism using a keratometer before and after the 2 types of scleral imbrications and compared the changes in ocular AL and corneal astigmatism induced by the 2 surgical procedures. Results The AL reduction after the scleral imbrication on all quadrants (3.96 ± 0.56 mm) was larger than that on 2 quadrants (2.39 ± 0.41 mm) (P = .001). The change in corneal astigmatism induced by imbrication on all quadrants (2.98 ± 1.96 D) was less than that on 2 quadrants (5.95 ± 2.04 D) (P < .029). Conclusions Scleral imbrication on all quadrants induced a shorter AL and less corneal astigmatism than did a standard scleral imbrication on 2 quadrants. Therefore, the former could be a more effective operation for retinal disorders associated with high myopia, including macular hole retinal detachment and myopic foveoschisis.
- 17 April 2022
- Published by Springer Nature in Japanese Journal of Ophthalmology
- Vol. 66 (3) , 335-340
Efficacy of scleral imbrication on all quadrants in enucleated pig eyes
Purpose To evaluate the changes in axial length (AL) and corneal astigmatism induced by scleral imbrication on all quadrants in pig eyes. Study design Experimental study Methods We produced scleral imbrications either on all quadrants or on 2 consecutive quadrants of 5 enucleated pig eyes. Scleral imbrications 8 mm wide were made at 8 mm from the limbus on each quadrant. We determined the AL using an electronic caliper and the corneal astigmatism using a keratometer before and after the 2 types of scleral imbrications and compared the changes in ocular AL and corneal astigmatism induced by the 2 surgical procedures. Results The AL reduction after the scleral imbrication on all quadrants (3.96 ± 0.56 mm) was larger than that on 2 quadrants (2.39 ± 0.41 mm) (P = .001). The change in corneal astigmatism induced by imbrication on all quadrants (2.98 ± 1.96 D) was less than that on 2 quadrants (5.95 ± 2.04 D) (P < .029). Conclusions Scleral imbrication on all quadrants induced a shorter AL and less corneal astigmatism than did a standard scleral imbrication on 2 quadrants. Therefore, the former could be a more effective operation for retinal disorders associated with high myopia, including macular hole retinal detachment and myopic foveoschisis.
- 1 May 2021
- Published by Elsevier in Ophthalmology Retina
- Vol. 5 (5) , 489-491
Visual Outcomes and Mechanism of Open-Globe Injuries with No Light Perception
- 1 May 2021
- Published by Elsevier in Ophthalmology Retina
- Vol. 5 (5) , 489-491
Visual Outcomes and Mechanism of Open-Globe Injuries with No Light Perception
- Open Access
- 1 December 2019
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 13, 2541-2546
Comparison of Surgical Outcomes Between Two Types of Lamellar Macular Holes
Purpose: The classification of lamellar macular holes (LMHs) into two subtypes has recently been proposed. However, the effectiveness of vitrectomy for treatment of each type of LMH is not well established. The goal of this study was to compare functional and anatomic changes after vitrectomy between eyes with degenerative LMH and those with tractional LMH. Patients and methods: This was a retrospective analysis of the medical records of patients with LMH who underwent vitrectomy. Best-corrected visual acuity (BCVA) and central macular thickness (CMT) were measured preoperatively (baseline), as well as at 1, 3 and 12 months postoperatively. BCVA and CMT were compared between eyes with degenerative LMH and those with tractional LMH. Results: Thirty-two eyes met the inclusion criteria. Thirteen eyes were diagnosed with degenerative LMH and 19 eyes were diagnosed with tractional LMH. Compared with baseline BCVA, postoperative BCVA improved significantly at 12 months postoperatively: from 0.33 to 0.12 logarithm of the minimum angle of resolution (logMAR) in eyes with degenerative LMH and from 0.30 to 0.12 logMAR in eyes with tractional LMH (p < 0.05 for both comparisons). BCVA at 12 months postoperatively did not significantly differ between the two groups. CMT decreased significantly from 419.4 μm at baseline to 364.2 μm at 12 months postoperatively in eyes with tractional LMH (p < 0.05); conversely, there was no significant difference in eyes with degenerative LMH (315.5 μm baseline to 314.9 μm at 12 months postoperatively; p > 0.05). Conclusion: Vitrectomy improved BCVA in eyes with degenerative LMH as well as in eyes with tractional LMH. BCVA at 12 months postoperatively did not differ between the two groups.
- 1 December 2019
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 13, 2541-2546
Open AccessComparison of Surgical Outcomes Between Two Types of Lamellar Macular Holes
Purpose: The classification of lamellar macular holes (LMHs) into two subtypes has recently been proposed. However, the effectiveness of vitrectomy for treatment of each type of LMH is not well established. The goal of this study was to compare functional and anatomic changes after vitrectomy between eyes with degenerative LMH and those with tractional LMH. Patients and methods: This was a retrospective analysis of the medical records of patients with LMH who underwent vitrectomy. Best-corrected visual acuity (BCVA) and central macular thickness (CMT) were measured preoperatively (baseline), as well as at 1, 3 and 12 months postoperatively. BCVA and CMT were compared between eyes with degenerative LMH and those with tractional LMH. Results: Thirty-two eyes met the inclusion criteria. Thirteen eyes were diagnosed with degenerative LMH and 19 eyes were diagnosed with tractional LMH. Compared with baseline BCVA, postoperative BCVA improved significantly at 12 months postoperatively: from 0.33 to 0.12 logarithm of the minimum angle of resolution (logMAR) in eyes with degenerative LMH and from 0.30 to 0.12 logMAR in eyes with tractional LMH (p < 0.05 for both comparisons). BCVA at 12 months postoperatively did not significantly differ between the two groups. CMT decreased significantly from 419.4 μm at baseline to 364.2 μm at 12 months postoperatively in eyes with tractional LMH (p < 0.05); conversely, there was no significant difference in eyes with degenerative LMH (315.5 μm baseline to 314.9 μm at 12 months postoperatively; p > 0.05). Conclusion: Vitrectomy improved BCVA in eyes with degenerative LMH as well as in eyes with tractional LMH. BCVA at 12 months postoperatively did not differ between the two groups.
- 8 November 2019
- Published by SAGE Publications in Journal of Vitreoretinal Diseases
- Vol. 4 (3) , 210-213
An Attachment Including a +20-D Lens to Gain Extended Field Images in Wide-Angle Optical Coherence Tomography Angiography
Purpose: This article evaluates the clinical usefulness of an attachment involving a +20-D lens to gain extended field images on wide-angle optical coherence tomography angiography (OCTA). Methods: An attachment with a +20-D lens was developed to take OCTA images of anterior segments, and it was used to obtain extended field images of the posterior segment in this study. Ten eyes of 5 individuals who did not have a history of ocular or systemic disease underwent wide-angle OCTA with a 12 × 12-mm center field using the PLEX Elite 9000 with and without the attachment. The ratio of the area of the center field to the area of the extended field with the attachment was calculated. Results: The mean area of the center image was 125 disc areas and that of the field extended by the attachment was 210 disc areas. The mean ratio between the center field and the extended field was 1.67. Conclusions: The attachment involving the +20-D lens seems to be clinically useful to gain extended field images on wide-angle OCTA.
- 8 November 2019
- Published by SAGE Publications in Journal of Vitreoretinal Diseases
- Vol. 4 (3) , 210-213
An Attachment Including a +20-D Lens to Gain Extended Field Images in Wide-Angle Optical Coherence Tomography Angiography
Purpose: This article evaluates the clinical usefulness of an attachment involving a +20-D lens to gain extended field images on wide-angle optical coherence tomography angiography (OCTA). Methods: An attachment with a +20-D lens was developed to take OCTA images of anterior segments, and it was used to obtain extended field images of the posterior segment in this study. Ten eyes of 5 individuals who did not have a history of ocular or systemic disease underwent wide-angle OCTA with a 12 × 12-mm center field using the PLEX Elite 9000 with and without the attachment. The ratio of the area of the center field to the area of the extended field with the attachment was calculated. Results: The mean area of the center image was 125 disc areas and that of the field extended by the attachment was 210 disc areas. The mean ratio between the center field and the extended field was 1.67. Conclusions: The attachment involving the +20-D lens seems to be clinically useful to gain extended field images on wide-angle OCTA.
- 30 April 2018
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 256 (7) , 1275-1280
Comparison between wide-angle OCT angiography and ultra-wide field fluorescein angiography for detecting non-perfusion areas and retinal neovascularization in eyes with diabetic retinopathy
To compare the ability of wide-angle optical coherence tomography angiography (OCTA) with that of ultra-wide field fluorescein angiography (UWFFA) to detect non-perfusion areas (NPAs) or retinal neovascularization (NV) in eyes with diabetic retinopathy (DR).
- 30 April 2018
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 256 (7) , 1275-1280
Comparison between wide-angle OCT angiography and ultra-wide field fluorescein angiography for detecting non-perfusion areas and retinal neovascularization in eyes with diabetic retinopathy
To compare the ability of wide-angle optical coherence tomography angiography (OCTA) with that of ultra-wide field fluorescein angiography (UWFFA) to detect non-perfusion areas (NPAs) or retinal neovascularization (NV) in eyes with diabetic retinopathy (DR).
- 1 November 2014
- Published by S. Karger AG in Ophthalmic Research
- Vol. 52 (4) , 234-238
Anterior Chamber Paracentesis Might Prevent Sustained Intraocular Pressure Elevation after Intravitreal Injections of Ranibizumab for Age-Related Macular Degeneration
Background/Aims: To evaluate the efficacy of anterior chamber paracentesis for preventing sustained intraocular pressure (IOP) elevation after intravitreal ranibizumab (IVR) injections for age-related macular degeneration (AMD). Methods: The medical records for all cases of exudative AMD treated with IVR injections and followed monthly for 12 months or longer were reviewed retrospectively. Anterior chamber paracentesis was performed just before IVR injections. A sustained IOP elevation was defined as 22 mm Hg or higher during 2 consecutive visits with an increase exceeding 6 mm Hg from baseline. Results: One hundred and eleven eyes met the inclusion criteria, and none of these eyes had a sustained IOP elevation. Conclusions: Anterior chamber paracentesis before IVR injections may prevent sustained IOP elevations.
- 1 November 2014
- Published by S. Karger AG in Ophthalmic Research
- Vol. 52 (4) , 234-238
Anterior Chamber Paracentesis Might Prevent Sustained Intraocular Pressure Elevation after Intravitreal Injections of Ranibizumab for Age-Related Macular Degeneration
Background/Aims: To evaluate the efficacy of anterior chamber paracentesis for preventing sustained intraocular pressure (IOP) elevation after intravitreal ranibizumab (IVR) injections for age-related macular degeneration (AMD). Methods: The medical records for all cases of exudative AMD treated with IVR injections and followed monthly for 12 months or longer were reviewed retrospectively. Anterior chamber paracentesis was performed just before IVR injections. A sustained IOP elevation was defined as 22 mm Hg or higher during 2 consecutive visits with an increase exceeding 6 mm Hg from baseline. Results: One hundred and eleven eyes met the inclusion criteria, and none of these eyes had a sustained IOP elevation. Conclusions: Anterior chamber paracentesis before IVR injections may prevent sustained IOP elevations.
- 1 December 2011
- Published by Wiley in Acta Ophthalmologica
- Vol. 91 (4) , 318-324
Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion
: Purpose: To compare the efficacy of intravitreal injections of triamcinolone acetonide (TA) and that of bevacizumab for macular oedema because of branch retinal vein occlusion (BRVO).Design: Prospective, comparative, randomized, interventional clinical trial.Methods: Forty‐three eyes of 43 patients with macular oedema because of BRVO were randomly assigned to 4‐mg intravitreal injections of TA (IVTA)(21 patients, IVTA group) or 1.25‐mg intravitreal injections of bevacizumab (IVB) (22 patients, IVB group) and followed for 12 months. No additional treatments were administered for 3 months after the initial injection; additional injections were administered when macular oedema recurred between 3 and 12 months after the initial injection. The best‐corrected visual acuity (BCVA) and the central retinal thickness (CRT) were measured at baseline and monthly. The main outcome measures were changes in the logarithm of the minimal angle of resolution BCVA and CRT from baseline to 12 months.Results: Eighteen eyes of 18 patients in the IVTA group and 18 eyes of 18 patients in the IVB group completed follow‐up at 12 months. The mean improvements in BCVA from baseline to 12 months were 0.12 in the IVTA group and 0.33 in the IVB group, which was significantly (p = 0.032) higher than in the IVTA group. There was no significant difference between the two groups in the mean reduction in CRT from baseline to 12 months after the initial injection. Two eyes in the IVTA group required intraocular pressure–lowering medications.Conclusion: Intravitreal injection of bevacizumab may be of greater benefit than that of TA for macular oedema because of BRVO.
- 1 December 2011
- Published by Wiley in Acta Ophthalmologica
- Vol. 91 (4) , 318-324
Prospective comparisons of intravitreal injections of triamcinolone acetonide and bevacizumab for macular oedema due to branch retinal vein occlusion
: Purpose: To compare the efficacy of intravitreal injections of triamcinolone acetonide (TA) and that of bevacizumab for macular oedema because of branch retinal vein occlusion (BRVO).Design: Prospective, comparative, randomized, interventional clinical trial.Methods: Forty‐three eyes of 43 patients with macular oedema because of BRVO were randomly assigned to 4‐mg intravitreal injections of TA (IVTA)(21 patients, IVTA group) or 1.25‐mg intravitreal injections of bevacizumab (IVB) (22 patients, IVB group) and followed for 12 months. No additional treatments were administered for 3 months after the initial injection; additional injections were administered when macular oedema recurred between 3 and 12 months after the initial injection. The best‐corrected visual acuity (BCVA) and the central retinal thickness (CRT) were measured at baseline and monthly. The main outcome measures were changes in the logarithm of the minimal angle of resolution BCVA and CRT from baseline to 12 months.Results: Eighteen eyes of 18 patients in the IVTA group and 18 eyes of 18 patients in the IVB group completed follow‐up at 12 months. The mean improvements in BCVA from baseline to 12 months were 0.12 in the IVTA group and 0.33 in the IVB group, which was significantly (p = 0.032) higher than in the IVTA group. There was no significant difference between the two groups in the mean reduction in CRT from baseline to 12 months after the initial injection. Two eyes in the IVTA group required intraocular pressure–lowering medications.Conclusion: Intravitreal injection of bevacizumab may be of greater benefit than that of TA for macular oedema because of BRVO.
- 25 October 2011
- Published by S. Karger AG in Ophthalmic Research
- Vol. 47 (3) , 135-140
Comparison between One Injection and Three Monthly Injections of Intravitreal Bevacizumab for Myopic Choroidal Neovascularization
Aim: To compare the effects of one intravitreal bevacizumab (IVB) injection with three monthly injections for myopic choroidal neovascularization. Methods: Group A included 13 patients treated with one IVB injection; group B included 19 patients treated with three monthly 1.25-mg IVB injections. All patients were followed monthly for 12 months with additional injections performed as needed. The best-corrected visual acuity (BCVA) and the central foveal thickness (CFT) on optical coherence tomography were evaluated before and after treatment. Results: The mean logMAR BCVA improved from 0.59 to 0.49 at 12 months in group A (p = 0.21) and from 0.65 to 0.29 in group B (p < 0.001); the improved logMAR BCVA differed significantly between the groups (p < 0.05). The mean CFT decreased from 231 µm at baseline to 150 µm at 12 months in group A (p < 0.05) and from 279 to 156 µm in group B (p < 0.001). During the follow-up, 6 of 13 eyes in group A and 5 of 19 eyes in group B received additional injections. Conclusions: Treatment starting with three monthly IVB injections may achieve better functional outcomes with fewer retreatments compared with treatment starting with one IVB injection.
- 25 October 2011
- Published by S. Karger AG in Ophthalmic Research
- Vol. 47 (3) , 135-140
Comparison between One Injection and Three Monthly Injections of Intravitreal Bevacizumab for Myopic Choroidal Neovascularization
Aim: To compare the effects of one intravitreal bevacizumab (IVB) injection with three monthly injections for myopic choroidal neovascularization. Methods: Group A included 13 patients treated with one IVB injection; group B included 19 patients treated with three monthly 1.25-mg IVB injections. All patients were followed monthly for 12 months with additional injections performed as needed. The best-corrected visual acuity (BCVA) and the central foveal thickness (CFT) on optical coherence tomography were evaluated before and after treatment. Results: The mean logMAR BCVA improved from 0.59 to 0.49 at 12 months in group A (p = 0.21) and from 0.65 to 0.29 in group B (p < 0.001); the improved logMAR BCVA differed significantly between the groups (p < 0.05). The mean CFT decreased from 231 µm at baseline to 150 µm at 12 months in group A (p < 0.05) and from 279 to 156 µm in group B (p < 0.001). During the follow-up, 6 of 13 eyes in group A and 5 of 19 eyes in group B received additional injections. Conclusions: Treatment starting with three monthly IVB injections may achieve better functional outcomes with fewer retreatments compared with treatment starting with one IVB injection.
- 1 July 2011
- Published by Springer Nature in Japanese Journal of Ophthalmology
- Vol. 55 (4) , 401-404
Negative correlation between aqueous vascular endothelial growth factor levels and axial length
The aim of this study was to evaluate the relationship between the concentrations of vascular endothelial growth factor (VEGF) in the aqueous humor and axial length. Aqueous humor samples were obtained from 60 eyes of 60 patients without ocular diseases other than cataracts. No patients with diabetes mellitus were included. The VEGF concentration in the aqueous humor was measured using an enzyme-linked immunosorbent assay. The VEGF concentrations in the aqueous humor samples ranged from 25 to 241 pg/ml [mean ± standard deviation (SD), 116.6 ± 46.7 pg/ml]. The axial lengths ranged from 20.98 to 31.95 mm (mean ± SD, 24.09 ± 2.06 mm). The VEGF concentrations in the aqueous humor samples were correlated with axial length (Pearson product moment correlation test, ρ = −0.373; P = 0.003). The concentration of VEGF in the aqueous humor is negatively correlated with axial length.
- 1 July 2011
- Published by Springer Nature in Japanese Journal of Ophthalmology
- Vol. 55 (4) , 401-404
Negative correlation between aqueous vascular endothelial growth factor levels and axial length
The aim of this study was to evaluate the relationship between the concentrations of vascular endothelial growth factor (VEGF) in the aqueous humor and axial length. Aqueous humor samples were obtained from 60 eyes of 60 patients without ocular diseases other than cataracts. No patients with diabetes mellitus were included. The VEGF concentration in the aqueous humor was measured using an enzyme-linked immunosorbent assay. The VEGF concentrations in the aqueous humor samples ranged from 25 to 241 pg/ml [mean ± standard deviation (SD), 116.6 ± 46.7 pg/ml]. The axial lengths ranged from 20.98 to 31.95 mm (mean ± SD, 24.09 ± 2.06 mm). The VEGF concentrations in the aqueous humor samples were correlated with axial length (Pearson product moment correlation test, ρ = −0.373; P = 0.003). The concentration of VEGF in the aqueous humor is negatively correlated with axial length.